Ruedi Wealth Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-479
Closed -$63.5K 58
2025
Q1
$63.5K Buy
479
+1
+0.2% +$127 0.02% 81
2024
Q4
$54.1K Buy
478
+1
+0.2% +$116 0.02% 84
2024
Q3
$54.4K Sell
477
-67
-12% -$7.35K 0.02% 84
2024
Q2
$56.5K Buy
544
+68
+14% +$7.21K 0.02% 81
2024
Q1
$54.1K Buy
476
+1
+0.2% +$115 0.02% 82
2023
Q4
$52.3K Buy
475
+46
+11% +$4.6K 0.02% 79
2023
Q3
$41.6K Hold
429
0.02% 82
2023
Q2
$46.8K Hold
429
0.03% 78
2023
Q1
$43.5K Hold
429
0.03% 87
2022
Q4
$47.1K Buy
+429
New +$44.4K 0.03% 74

Other funds holding ABT

Ruedi Wealth Management's ABT Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Abbott (ABT) in Q2 2025, closing a stake of 479 shares — an estimated $63.5K sold.

Ruedi Wealth Management first reported a position in ABT in Q4 2022 and held it in 10 quarters. The position peaked at $63.5K in Q1 2025. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 479 Abbott shares in Q2 2025, an estimated $63.5K.
  • Ruedi Wealth Management first reported a position in Abbott in Q4 2022 and held it in 10 quarters.
  • Ruedi Wealth Management's Abbott position peaked at $63.5K in Q1 2025.
  • 3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.